Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
123,850,680
-
Total 13F shares
-
91,798,770
-
Share change
-
-1,940,724
-
Total reported value
-
$9,181,331,846
-
Put/Call ratio
-
55%
-
Price per share
-
$100.02
-
Number of holders
-
371
-
Value change
-
-$246,580,576
-
Number of buys
-
169
-
Number of sells
-
180
Institutional Holders of Guardant Health, Inc. - Common Stock (GH) as of Q4 2021
As of 31 Dec 2021,
Guardant Health, Inc. - Common Stock (GH) was held by
371 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
91,798,770 shares.
The largest 10 holders included
VANGUARD GROUP INC, Capital Research Global Investors, FMR LLC, MORGAN STANLEY, BlackRock Inc., VIKING GLOBAL INVESTORS LP, Clearbridge Investments, LLC, Capital International Investors, Nuveen Asset Management, LLC, and CREDIT SUISSE AG/.
This page lists
373
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.